Nobori Dual Antiplatelet Therapy as Appropriate Duration
NCT01514227
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
3773
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DRUG:
Aspirin or thienopyridine
DRUG:
Aspirin and thienopyridine
Sponsor
Associations for Establishment of Evidence in Interventions